Baicalein attenuates hypertrophic scar formation via inhibition of the transforming growth factor-β/Smad2/3 signalling pathway. [electronic resource]
Producer: 20161213Description: 120-30 p. digitalISSN:- 1365-2133
- Adolescent
- Adult
- Animals
- Antioxidants -- pharmacology
- Child
- Cicatrix, Hypertrophic -- drug therapy
- Dermatologic Agents -- pharmacology
- Female
- Fibroblasts -- drug effects
- Flavanones -- pharmacology
- Humans
- Male
- Mice, Inbred BALB C
- Protein Serine-Threonine Kinases -- drug effects
- Receptor, Transforming Growth Factor-beta Type I
- Receptors, Transforming Growth Factor beta -- drug effects
- Signal Transduction -- drug effects
- Smad2 Protein -- antagonists & inhibitors
- Smad3 Protein -- antagonists & inhibitors
- Transforming Growth Factor beta1 -- antagonists & inhibitors
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.